Amdocs (DOX) Stock Forecast, Price Target & Predictions
DOX Stock Forecast
Amdocs stock forecast is as follows: an average price target of $97.80 (represents a 14.79% upside from DOX’s last price of $85.20) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
DOX Price Target
The average price target for Amdocs (DOX) is $97.80 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $105.00 to $90.00. This represents a potential 14.79% upside from DOX's last price of $85.20.
DOX Analyst Ratings
According to 3 Wall Street analysts, Amdocs's rating consensus is 'Buy'. The analyst rating breakdown for DOX stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Amdocs Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 13, 2024 | Shaul Eyal | Oppenheimer | - | - | 26.48% | 23.24% |
| Oct 01, 2024 | Tom Roderick | Stifel Nicolaus | - | - | 14.44% | 17.37% |
| May 09, 2024 | William Power | Robert W. Baird | - | - | 4.76% | 5.63% |
| Feb 01, 2023 | Oppenheimer | - | - | 7.69% | 16.20% | |
| Aug 04, 2022 | Barclays | - | - | 10.83% | 11.50% | |
| Aug 04, 2022 | Citigroup | - | - | 15.49% | 16.20% |
The latest Amdocs stock forecast, released on Nov 13, 2024 by Shaul Eyal from Oppenheimer, set a price target of $105.00, which represents a 26.48% increase from the stock price at the time of the forecast ($83.02), and a 23.24% increase from DOX last price ($85.20).
Amdocs Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 2 | 3 |
| Avg Price Target | $105.00 | $102.50 | $98.33 |
| Last Closing Price | $85.20 | $85.20 | $85.20 |
| Upside/Downside | 23.24% | 20.31% | 15.41% |
In the current month, the average price target of Amdocs stock is $105.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 23.24% increase as opposed to Amdocs's last price of $85.20. This month's average price target is up 2.44% compared to last quarter, and up 6.78% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 09, 2024 | Citigroup | Buy | Buy | Hold |
| May 16, 2023 | Barclays | Equal-Weight | Overweight | Upgrade |
| Feb 01, 2023 | Oppenheimer | Outperform | Outperform | Hold |
| Aug 04, 2022 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Aug 04, 2022 | Citigroup | Buy | Buy | Hold |
Amdocs's last stock rating was published by Citigroup on May 09, 2024. The company gave DOX a "Buy" rating, the same as its previous rate.
Amdocs Financial Forecast
Amdocs Revenue Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.22B | $1.19B | $1.17B | $1.16B | $1.15B | $1.10B | $1.09B | $1.07B | $1.05B | $1.09B | $1.05B | $1.03B | $1.05B | $1.04B | $1.03B | $1.02B |
| Avg Forecast | $1.18B | $1.17B | $1.16B | $1.15B | $1.15B | $1.13B | $1.12B | $1.11B | $1.26B | $1.25B | $1.25B | $1.24B | $1.24B | $1.24B | $1.22B | $1.18B | $1.17B | $1.16B | $1.13B | $1.10B | $1.09B | $1.06B | $1.04B | $1.08B | $1.03B | $1.01B | $1.04B | $1.03B | $1.03B | $1.03B |
| High Forecast | $1.22B | $1.20B | $1.19B | $1.18B | $1.18B | $1.17B | $1.23B | $1.13B | $1.26B | $1.25B | $1.25B | $1.25B | $1.24B | $1.27B | $1.25B | $1.21B | $1.17B | $1.16B | $1.13B | $1.10B | $1.09B | $1.06B | $1.04B | $1.08B | $1.03B | $1.01B | $1.04B | $1.03B | $1.03B | $1.03B |
| Low Forecast | $1.17B | $1.15B | $1.14B | $1.14B | $1.14B | $1.12B | $1.07B | $1.10B | $1.26B | $1.25B | $1.25B | $1.23B | $1.24B | $1.22B | $1.20B | $1.17B | $1.17B | $1.16B | $1.13B | $1.10B | $1.09B | $1.06B | $1.04B | $1.08B | $1.03B | $1.01B | $1.04B | $1.03B | $1.03B | $1.03B |
| # Analysts | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 3 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.00% | 1.00% | 1.00% | 1.02% | 1.00% | 1.00% | 1.00% | 1.01% | 1.01% | 1.02% | 1.01% | 1.00% | 1.01% | 1.00% | 1.00% |
Amdocs's average Quarter revenue forecast for Jun 23 based on 2 analysts is $1.24B, with a low forecast of $1.22B, and a high forecast of $1.27B. DOX's average Quarter revenue forecast represents a 1.02% increase compared to the company's last Quarter revenue of $1.22B (Mar 23).
Amdocs EBITDA Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 3 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $224.29M | $235.68M | $189.52M | $242.96M | $213.85M | $218.46M | $205.04M | $210.98M | $198.84M | $418.32M | $199.62M | $194.14M | $205.82M | $192.58M | $196.72M | $195.72M |
| Avg Forecast | $235.01M | $231.86M | $229.71M | $228.35M | $228.88M | $225.34M | $222.89M | $221.48M | $250.90M | $249.26M | $198.72M | $247.07M | $246.55M | $245.47M | $180.66M | $236.23M | $209.32M | $208.39M | $164.23M | $197.66M | $196.30M | $190.64M | $198.84M | $193.36M | $185.69M | $181.66M | $201.94M | $185.60M | $185.35M | $184.15M |
| High Forecast | $241.55M | $238.32M | $236.11M | $234.72M | $235.26M | $231.62M | $243.84M | $223.48M | $250.96M | $249.26M | $238.47M | $249.05M | $247.15M | $252.31M | $216.79M | $283.48M | $209.32M | $208.39M | $197.08M | $197.66M | $196.30M | $190.64M | $238.60M | $193.36M | $185.69M | $181.66M | $242.32M | $185.60M | $185.35M | $184.15M |
| Low Forecast | $232.04M | $228.93M | $226.81M | $225.47M | $225.99M | $222.49M | $213.36M | $218.68M | $250.84M | $249.26M | $158.98M | $245.09M | $246.23M | $242.37M | $144.53M | $188.99M | $209.32M | $208.39M | $131.39M | $197.66M | $196.30M | $190.64M | $159.07M | $193.36M | $185.69M | $181.66M | $161.55M | $185.60M | $185.35M | $184.15M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.24% | 1.00% | 0.91% | 1.17% | 1.30% | 1.11% | 1.04% | 1.11% | 1.00% | 2.16% | 1.08% | 1.07% | 1.02% | 1.04% | 1.06% | 1.06% |
2 analysts predict DOX's average Quarter EBITDA for Jun 23 to be $245.47M, with a high of $252.31M and a low of $242.37M. This is 9.44% upper than Amdocs's previous annual EBITDA (Mar 23) of $224.29M.
Amdocs Net Income Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 3 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $149.60M | $129.67M | $128.94M | $128.47M | $158.50M | $133.60M | $123.53M | $146.15M | $119.07M | $299.63M | $134.46M | $120.41M | $127.04M | $115.93M | $122.03M | $131.45M |
| Avg Forecast | $228.13M | $222.62M | $216.85M | $209.53M | $213.70M | $205.24M | $197.77M | $189.16M | $196.31M | $185.22M | $147.29M | $180.68M | $163.71M | $170.99M | $133.90M | $144.47M | $149.10M | $146.30M | $121.73M | $136.81M | $135.96M | $139.04M | $119.07M | $132.47M | $136.93M | $121.18M | $124.64M | $121.71M | $124.42M | $128.55M |
| High Forecast | $236.39M | $230.69M | $224.70M | $217.12M | $221.44M | $212.67M | $201.20M | $191.40M | $196.37M | $185.22M | $176.75M | $181.83M | $169.64M | $177.18M | $160.68M | $173.37M | $150.19M | $152.75M | $146.07M | $136.81M | $139.93M | $139.04M | $142.88M | $132.47M | $136.93M | $121.18M | $149.57M | $121.71M | $124.42M | $128.55M |
| Low Forecast | $224.38M | $218.97M | $213.29M | $206.09M | $210.19M | $201.87M | $194.34M | $183.56M | $196.25M | $185.21M | $117.83M | $179.53M | $162.56M | $168.18M | $107.12M | $115.58M | $148.02M | $139.86M | $97.38M | $136.81M | $132.00M | $139.04M | $95.25M | $132.47M | $136.93M | $121.18M | $99.71M | $121.71M | $124.42M | $128.55M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.12% | 0.90% | 0.86% | 0.88% | 1.30% | 0.98% | 0.91% | 1.05% | 1.00% | 2.26% | 0.98% | 0.99% | 1.02% | 0.95% | 0.98% | 1.02% |
Amdocs's average Quarter net income forecast for Jun 23 is $170.99M, with a range of $168.18M to $177.18M. DOX's average Quarter net income forecast represents a 14.29% increase compared to the company's last Quarter net income of $149.60M (Mar 23).
Amdocs SG&A Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 3 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $143.33M | $143.22M | $129.40M | $136.11M | $134.98M | $128.08M | $126.02M | $122.40M | $116.95M | $121.89M | $106.35M | $109.61M | $119.11M | $123.47M | $125.05M | $125.09M |
| Avg Forecast | $136.38M | $134.55M | $133.30M | $132.52M | $132.82M | $130.76M | $129.34M | $128.53M | $145.60M | $144.65M | $125.44M | $143.38M | $143.07M | $142.45M | $114.03M | $138.50M | $134.32M | $133.72M | $103.67M | $126.84M | $125.96M | $122.33M | $116.95M | $124.08M | $119.16M | $116.57M | $116.86M | $119.10M | $118.94M | $118.17M |
| High Forecast | $140.18M | $138.30M | $137.02M | $136.21M | $136.52M | $134.41M | $141.50M | $129.68M | $145.63M | $144.65M | $150.52M | $144.52M | $143.42M | $146.42M | $136.84M | $166.19M | $134.32M | $133.72M | $124.40M | $126.84M | $125.96M | $122.33M | $140.34M | $124.08M | $119.16M | $116.57M | $140.23M | $119.10M | $118.94M | $118.17M |
| Low Forecast | $134.65M | $132.85M | $131.62M | $130.84M | $131.15M | $129.11M | $123.82M | $126.90M | $145.56M | $144.65M | $100.35M | $142.23M | $142.89M | $140.65M | $91.23M | $110.80M | $134.32M | $133.72M | $82.93M | $126.84M | $125.96M | $122.33M | $93.56M | $124.08M | $119.16M | $116.57M | $93.49M | $119.10M | $118.94M | $118.17M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.26% | 1.03% | 0.96% | 1.02% | 1.30% | 1.01% | 1.00% | 1.00% | 1.00% | 0.98% | 0.89% | 0.94% | 1.02% | 1.04% | 1.05% | 1.06% |
Amdocs's average Quarter SG&A projection for Jun 23 is $142.45M, based on 2 Wall Street analysts, with a range of $140.65M to $146.42M. The forecast indicates a -0.61% fall compared to DOX last annual SG&A of $143.33M (Mar 23).
Amdocs EPS Forecast
| Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 3 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 9 | 9 | 9 | 5 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.24 | $1.07 | $1.06 | $1.05 | $1.29 | $1.09 | $0.98 | $1.15 | $0.92 | $2.29 | $1.02 | $0.90 | $0.95 | $0.86 | $0.90 | $0.96 |
| Avg Forecast | $1.97 | $1.93 | $1.88 | $1.81 | $1.85 | $1.78 | $1.71 | $1.64 | $1.70 | $1.60 | $1.57 | $1.56 | $1.42 | $1.48 | $1.47 | $1.34 | $1.29 | $1.27 | $1.25 | $1.18 | $1.18 | $1.20 | $1.13 | $1.15 | $1.19 | $1.05 | $1.06 | $1.05 | $1.08 | $1.11 |
| High Forecast | $2.05 | $2.00 | $1.94 | $1.88 | $1.92 | $1.84 | $1.74 | $1.66 | $1.70 | $1.60 | $1.58 | $1.57 | $1.47 | $1.53 | $1.49 | $1.39 | $1.30 | $1.32 | $1.25 | $1.18 | $1.21 | $1.20 | $1.13 | $1.15 | $1.19 | $1.05 | $1.06 | $1.05 | $1.08 | $1.11 |
| Low Forecast | $1.94 | $1.90 | $1.85 | $1.78 | $1.82 | $1.75 | $1.68 | $1.59 | $1.70 | $1.60 | $1.57 | $1.55 | $1.41 | $1.46 | $1.45 | $1.32 | $1.28 | $1.21 | $1.25 | $1.18 | $1.14 | $1.20 | $1.13 | $1.15 | $1.19 | $1.05 | $1.06 | $1.05 | $1.08 | $1.11 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.84% | 0.80% | 0.82% | 0.83% | 1.03% | 0.92% | 0.83% | 0.96% | 0.81% | 2.00% | 0.86% | 0.86% | 0.89% | 0.82% | 0.84% | 0.86% |
According to 2 Wall Street analysts, Amdocs's projected average Quarter EPS for Jun 23 is $1.48, with a low estimate of $1.46 and a high estimate of $1.53. This represents a 19.34% increase compared to DOX previous annual EPS of $1.24 (Mar 23).
Amdocs Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| AKAM | Akamai | - | - | 31.83% | Buy |
| VRSN | VeriSign | - | - | 29.80% | Buy |
| WEX | WEX | - | - | 20.97% | Hold |
| DOX | Amdocs | - | - | 14.79% | Buy |
| CCSI | Consensus Cloud Solutions | - | - | 5.26% | Buy |
| QLYS | Qualys | - | - | -2.12% | Buy |
| FLT | Corpay | - | - | -2.16% | Buy |
| CSGS | CSG Systems | - | - | -5.80% | Buy |
| FFIV | F5 | - | - | -8.13% | Hold |
| CHKP | Check Point Software | - | - | -12.04% | Buy |
| EVTC | EVERTEC | - | - | -12.65% | Sell |
| CYBR | CyberArk Software | - | - | -20.23% | Buy |